
### [NCIT:C138195](http://purl.obolibrary.org/obo/NCIT_C138195)
**Label:** High Grade B-Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements

**Subclasses:** [NCIT:C131913](http://purl.obolibrary.org/obo/NCIT_C131913) (High-Grade B-Cell Lymphoma with MYC, BCL2, and BCL6 Rearrangements), [NCIT:C125904](http://purl.obolibrary.org/obo/NCIT_C125904) (High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements), 

**Class expressions from DL-Learner:**

- [NCIT:C132018](http://purl.obolibrary.org/obo/NCIT_C132018) (MYC Gene Rearrangement) 60.00%
- Thing 51.82%
- [NCIT:C133155](http://purl.obolibrary.org/obo/NCIT_C133155) (Gene Rearrangement Abnormality) 46.98%
- [NCIT:C132020](http://purl.obolibrary.org/obo/NCIT_C132020) (BCL6 Gene Rearrangement) 45.36%
- [NCIT:C132020](http://purl.obolibrary.org/obo/NCIT_C132020) (BCL6 Gene Rearrangement) and (not ([NCIT:C36102](http://purl.obolibrary.org/obo/NCIT_C36102) (Hereditary Ovarian Carcinoma))) 45.36%
- [NCIT:C132020](http://purl.obolibrary.org/obo/NCIT_C132020) (BCL6 Gene Rearrangement) and (not ([NCIT:C36101](http://purl.obolibrary.org/obo/NCIT_C36101) (BRCA2 Syndrome))) 45.36%
- [NCIT:C132020](http://purl.obolibrary.org/obo/NCIT_C132020) (BCL6 Gene Rearrangement) and (not ([NCIT:C36100](http://purl.obolibrary.org/obo/NCIT_C36100) (BRCA1 Syndrome))) 45.36%
- [NCIT:C132020](http://purl.obolibrary.org/obo/NCIT_C132020) (BCL6 Gene Rearrangement) and (not ([NCIT:C36097](http://purl.obolibrary.org/obo/NCIT_C36097) (Cervical Carcinosarcoma))) 45.36%
- [NCIT:C132020](http://purl.obolibrary.org/obo/NCIT_C132020) (BCL6 Gene Rearrangement) and (not ([NCIT:C36089](http://purl.obolibrary.org/obo/NCIT_C36089) (Atypical Breast Papilloma))) 45.36%
- [NCIT:C132020](http://purl.obolibrary.org/obo/NCIT_C132020) (BCL6 Gene Rearrangement) and (not ([NCIT:C36088](http://purl.obolibrary.org/obo/NCIT_C36088) (Peripheral Breast Papilloma))) 45.36%
- [NCIT:C132020](http://purl.obolibrary.org/obo/NCIT_C132020) (BCL6 Gene Rearrangement) and (not ([NCIT:C36085](http://purl.obolibrary.org/obo/NCIT_C36085) (Invasive Papillary Breast Carcinoma))) 45.36%
- [NCIT:C132020](http://purl.obolibrary.org/obo/NCIT_C132020) (BCL6 Gene Rearrangement) and (not ([NCIT:C36081](http://purl.obolibrary.org/obo/NCIT_C36081) (Diffuse Large B-Cell Lymphoma Activated B-Cell Type))) 45.36%
- [NCIT:C132020](http://purl.obolibrary.org/obo/NCIT_C132020) (BCL6 Gene Rearrangement) and (not ([NCIT:C36080](http://purl.obolibrary.org/obo/NCIT_C36080) (Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type))) 45.36%
- [NCIT:C132020](http://purl.obolibrary.org/obo/NCIT_C132020) (BCL6 Gene Rearrangement) and (not ([NCIT:C36074](http://purl.obolibrary.org/obo/NCIT_C36074) (Metastatic Peripheral Primitive Neuroectodermal Tumor of Bone))) 45.36%
- [NCIT:C132020](http://purl.obolibrary.org/obo/NCIT_C132020) (BCL6 Gene Rearrangement) and (not ([NCIT:C36062](http://purl.obolibrary.org/obo/NCIT_C36062) (Chronic Myelomonocytic Leukemia-2))) 45.36%


